Global Stent Market to Surpass $ 16 Bn by 2025

February 19, 2020


As per the report titled ‘Stent Market Size By Type (Coronary, Peripheral Vascular {Iliac, Femoral-Popliteal, Renal, Carotid}), By Technology (Bare Metal Stent, Drug Eluting Stent, Bioresorbable Stent), By Mode of Delivery (Self-Expandable, Balloon Expandable), By End-use (Hospitals, Ambulatory Surgical Centres), By Material (Metal, Polymer), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, China, Japan, India, Australia, Singapore, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025’ available with Market Study Report LLC, the global stent market is anticipated to accumulate USD 16 billion by the year 2025.
 

Rising preference for minimally invasive procedures in conjunction with increasing number of coronary artery and peripheral artery surgeries are fueling the growth of stent market. Surge in cardiovascular surgeries, adoption of inactive lifestyle, and increasing geriatric population which is more prone to cardiovascular disorders are other factors propelling the market growth.
 

Notably, technological advancements have improved the efficacy of stents as a part of cardiovascular procedures. This factor coupled with growing availability of various cardiovascular procedures will enhance the market outlook. Furthermore, increasing R&D activities and favorable government initiatives will positively impact the market growth over the analysis period. On the contrary, stringent regulatory norms for approval of stents, cases of stent failure, and product recalls will restrain the market expansion to some extent.
 

Based on the technology, drug eluting stent market segment registered 40% share in 2018 and is anticipated to grow significantly over the forecast timeline. These stents slowly release drug to check cell proliferation and are highly effective in preventing restenosis of arteries.
 

Speaking of the mode of delivery, balloon expandable segment accounted for 70% share of stent market in 2018 and is expected to follow similar trend during the study period. The segment growth can be attributed to the benefit of improved radial stiffness, along with high adoption rate and favorable approval standards for balloon expandable stents.
 

Considering the geographical outlook, U.S. stent market accounted for majority share in 2018 and is projected to grow with a CAGR of 2.4% through 2025. Favorable reimbursement scenario, increasing geriatric population, high healthcare expenditure, and inflowing investments by stent manufacturers are driving the regional growth.

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2100675/
 

On the other hand, Germany stent market is expected to grow with a CAGR of 2.7% during 2019-2025, on account of high adoption of advanced technologies, rising baby boomer population, and increasing incidences of cardiovascular disorders in the region.
 

Major players of stent market include Abbott Laboratories, B. Braun Melsungen AG, Medtronic, Terumo, MicroPort Scientific Corporation, C R Bard, Biotronik SE & Co. KG, Boston Scientific, Biosensors International Group, Elixir Medical Corporation, and Meril Life Sciences.


Frequently Asked Questions (FAQ) :

Rising preference for minimally invasive procedures in conjunction with increasing number of coronary artery and peripheral artery surgeries are fueling the growth of stent market. Surge in cardiovascular surgeries, adoption of inactive lifestyle and increasing geriatric population which is more prone to cardiovascular disorders are other factors propelling the market growth. Notably, technological advancements have improved the efficacy of stents as a part of cardiovascular procedures. This factor coupled with growing availability of various cardiovascular procedures will enhance the market outlook. Furthermore, increasing R&D activities and favorable government initiatives will positively impact the market growth over the analysis period.
Drug eluting stent market segment accounted for 40% share in 2018 and is anticipated to grow significantly over the forecast timeline. These stents slowly release drug to check cell proliferation and are highly effective in preventing restenosis of arteries.
U.S. stent market accounted for majority share in 2018 and is projected to grow with a CAGR of 2.4% through 2025. Favorable reimbursement scenario, increasing geriatric population, high healthcare expenditure, and inflowing investments by stent manufacturers are driving the regional growth.
Major players of stent market include Abbott Laboratories, B. Braun Melsungen AG, Medtronic, Terumo, MicroPort Scientific Corporation, C R Bard, Biotronik SE & Co. KG, Boston Scientific, Biosensors International Group, Elixir Medical Corporation, and Meril Life Sciences.